Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺43.059,97, with a 24-hour trading volume of ₺40,5B. The asset's market cap is ₺38,44T, after moving -0.62% in the last day.
Tokenized Eli Lilly And Co is trading at ₺43.171,49, with a tokenized market cap of ₺236,17M and a 24-hour trading volume of ₺106,27M. The tokenized asset has moved 0.59% in the past 24 hours.